| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/28/2010 | US20100022577 Dry syrup containing loratadine |
| 01/28/2010 | US20100022555 Novel Derivatives |
| 01/28/2010 | US20100022554 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 01/28/2010 | US20100022550 Tetrahydrocarbazole derivatives useful as androgen receptor modulators |
| 01/28/2010 | US20100022546 Adamantyl diamide derivatives and uses of same |
| 01/28/2010 | US20100022540 Triazole derivatives ii |
| 01/28/2010 | US20100022539 Isoxazole Compounds as Histamine H3 modulators |
| 01/28/2010 | US20100022537 I-pheny 1-3,4-dihydropyrimidin-2(1h)-one derivatives and their use |
| 01/28/2010 | US20100022535 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 Inhibitors |
| 01/28/2010 | US20100022529 Amidophenoxyindazoles useful as inhibitors of c-met |
| 01/28/2010 | US20100022528 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022519 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 01/28/2010 | US20100022518 Novel heterocyclyl compounds |
| 01/28/2010 | US20100022516 4,5-Disubstituted-2-aryl pyrimidines |
| 01/28/2010 | US20100022515 Compounds and compositions as modulators of gpr119 activity |
| 01/28/2010 | US20100022514 Heterocycle Compounds and Methods of Use Thereof |
| 01/28/2010 | US20100022503 tyrosine kinase inhibitors such as Ethyl 3-(3-(pyrrolo[1,2-f][1,2,4]triazin-4-ylamino)-1H-pyrazol-5-ylthio)benzoate, useful as anticarcinogenic or antiproliferative agents |
| 01/28/2010 | US20100022502 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 01/28/2010 | US20100022476 Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 01/28/2010 | CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | CA2731773A1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 01/28/2010 | CA2731254A1 Process for the preparation of esomeprazole magnesium in a stable form |
| 01/28/2010 | CA2731190A1 Pyridinyl modulators of .gamma.-secretase |
| 01/28/2010 | CA2731146A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/28/2010 | CA2730500A1 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid deri vatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/28/2010 | CA2730158A1 Insecticidal phenyl- or pyridyl-piperidine compounds |
| 01/28/2010 | CA2728629A1 Adamantyl diamide derivatives and uses of same |
| 01/27/2010 | EP2147918A1 Process for the preparation of S-omeprazole magnesium in a stable form |
| 01/27/2010 | EP2147917A1 One-pot production process for cinnamide derivative |
| 01/27/2010 | EP2146980A2 Histamine h3 receptor ligands comprising a cyclobutoxy group |
| 01/27/2010 | EP2146979A1 A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701 |
| 01/27/2010 | EP2146978A1 Imatinib production process |
| 01/27/2010 | EP2146969A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
| 01/27/2010 | EP2146967A2 Tetrahydroindole and tetrahydroindazole derivatives |
| 01/27/2010 | EP2146964A2 Ethers of naphtalene carboxylic acid amides as cancer cure |
| 01/27/2010 | EP2146963A2 Dual-acting antihypertensive agents |
| 01/27/2010 | EP2146959A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 01/27/2010 | EP2146957A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 01/27/2010 | EP2146779A1 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/27/2010 | EP2146720A1 Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/27/2010 | EP2146718A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146717A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146716A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 01/27/2010 | EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
| 01/27/2010 | EP2044051B1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 01/27/2010 | EP1919903B1 Bicyclic bisamide derivatives and use thereof as insecticides |
| 01/27/2010 | EP1893581B1 Substituted arylpyrazoles for use against parasitites |
| 01/27/2010 | EP1748998B1 A novel stereoselective synthesis of benzimidazole sulfoxides |
| 01/27/2010 | EP1656353B1 Gabanergic modulators |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | CN101636395A Novel 2-heteroaryl substituted indoles 695 |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101632668A Oral pharmaceutical composition |
| 01/27/2010 | CN100586244C Compound, charge transporting material and organic electroluminescent element |
| 01/27/2010 | CN100584832C 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 01/27/2010 | CN100584830C Gabanergic modulators |
| 01/27/2010 | CN100584331C Use of immunomudulatory compounds in preparing medicine for the treatment, control or prevention of myeloproliferative diseases |
| 01/26/2010 | US7652153 Caspase inhibitors and uses thereof |
| 01/26/2010 | US7652150 [2-(4-Fluoro-]. H-indol-3-ylsulfanyl)benzyl]dimethyl amine; depression, anxiety disorders including general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652143 2-(3-(4-benzyloxybenzyl)-2-oxoimidazolidin-1-yl)-N-hydroxy-3-methylbutyramide; N-hydroxy-3-methyl-2-{2-oxo-3-(4-(pyridin-4-ylmethoxy)benzyl)imidazolidin-1-yl}butyramide with trifluoroacetic acid ; osteoarthrosis and rheumatoid arthritis; TNF- alpha converting enzyme (TACE) inhibitor |
| 01/26/2010 | US7652142 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
| 01/26/2010 | US7652134 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral; contacting the corresponding ester with an amine and a Lewis acid |
| 01/26/2010 | US7652061 (R)-1-{2-[3-(5-Methyl-2-pheny-oxazol-4-ylmethoxy)-phenyl]-acetyl}-pyrrolidine-2-carboxylic acid; dyslipidemia, hyperlipidemia, hypercholesteremia, or type-2 diabetes |
| 01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
| 01/26/2010 | US7652056 Using 4-imidazoline carboxylic acid or ester; antiinflammatory agents; microbiocides; bactericides; antitumor agenst0 |
| 01/26/2010 | US7652051 3-amino-benzo[1,2,4]triazine-7-ol-1-oxide; 4-[3-(4-chloro-phenylamino)-benzo[1,2,4]triazin-7-yloxy]-pyridine-2-carboxylic acid methylamide trifluoroacetate salt; modulation of the MAPK pathway; cancer |
| 01/26/2010 | US7652043 Inhibiting aberrant growth states in cells having Wnt receptors; carcinoma |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652019 5,6-trimethylenepyrimidin-4-one compounds |
| 01/26/2010 | US7652015 Kinase inhibitors |
| 01/26/2010 | US7652014 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/26/2010 | US7652011 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine |
| 01/26/2010 | US7652010 Azabicyclic aryl derivatives and their medical use |
| 01/26/2010 | US7652009 Substituted heterocycles and methods of use |
| 01/26/2010 | CA2469380C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2430579C Isoindolin-1-one glucokinase activators |
| 01/26/2010 | CA2403686C Substituted piperidines as melanocortin receptor agonists |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2010009402A2 Nilotinib intermediates and preparation thereof |
| 01/21/2010 | WO2010009290A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | WO2010009212A1 Niacin derivatives useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009183A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | WO2010008739A2 Aryl gpr119 agonists and uses thereof |
| 01/21/2010 | WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007966A1 Azole compound |
| 01/21/2010 | WO2010007943A1 Nitrogenated heterocyclic compound |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007382A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 01/21/2010 | WO2010007374A1 Pharmaceutical compounds |
| 01/21/2010 | WO2010007120A1 Pyridazine derivatives as smo inhibitors |
| 01/21/2010 | WO2010007116A2 New chemical compounds |
| 01/21/2010 | WO2010007114A2 New chemical compounds |